Report Detail

Pharma & Healthcare Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Insights, Forecast to 2025

  • RnM2953984
  • |
  • 16 February, 2019
  • |
  • Global
  • |
  • 117 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

The global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b market based on company, product type, end user and key regions.

This report studies the global market size of Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b in these regions.
This research report categorizes the global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b market by top players/brands, region, type and end user. This report also studies the global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
BioInvent International AB
MacroGenics, Inc.
Shire Plc
Xencor, Inc.

Market size by Product
XmAb-7195
BI-1206
MGD-010
SM-201
Others
Market size by End User
Hospital
Clinic
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Size Growth Rate by Product
      • 1.4.2 XmAb-7195
      • 1.4.3 BI-1206
      • 1.4.4 MGD-010
      • 1.4.5 SM-201
      • 1.4.6 Others
    • 1.5 Market by End User
      • 1.5.1 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Size Growth Rate by End User
      • 1.5.2 Hospital
      • 1.5.3 Clinic
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Size
      • 2.1.1 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue 2014-2025
      • 2.1.2 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales 2014-2025
    • 2.2 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Growth Rate by Regions
      • 2.2.1 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales by Regions
      • 2.2.2 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales by Manufacturers
      • 3.1.1 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales by Manufacturers
      • 3.1.2 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Market Share by Manufacturers
      • 3.1.3 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Concentration Ratio (CR5 and HHI)
    • 3.2 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Manufacturers
      • 3.2.1 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Manufacturers (2014-2019)
      • 3.2.2 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Share by Manufacturers (2014-2019)
    • 3.3 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Price by Manufacturers
    • 3.4 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Manufacturing Base Distribution, Product Types
      • 3.4.1 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Product Type
      • 3.4.3 Date of International Manufacturers Enter into Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales by Product
    • 4.2 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Product
    • 4.3 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Breakdown Data by End User

    6 North America

    • 6.1 North America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b by Countries
      • 6.1.1 North America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales by Countries
      • 6.1.2 North America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b by Product
    • 6.3 North America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b by End User

    7 Europe

    • 7.1 Europe Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b by Countries
      • 7.1.1 Europe Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales by Countries
      • 7.1.2 Europe Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b by Product
    • 7.3 Europe Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b by Countries
      • 8.1.1 Asia Pacific Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales by Countries
      • 8.1.2 Asia Pacific Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b by Product
    • 8.3 Asia Pacific Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b by End User

    9 Central & South America

    • 9.1 Central & South America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b by Countries
      • 9.1.1 Central & South America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales by Countries
      • 9.1.2 Central & South America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b by Product
    • 9.3 Central & South America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b by Countries
      • 10.1.1 Middle East and Africa Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales by Countries
      • 10.1.2 Middle East and Africa Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b by Product
    • 10.3 Middle East and Africa Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b by End User

    11 Company Profiles

    • 11.1 BioInvent International AB
      • 11.1.1 BioInvent International AB Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 BioInvent International AB Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 BioInvent International AB Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Products Offered
      • 11.1.5 BioInvent International AB Recent Development
    • 11.2 MacroGenics, Inc.
      • 11.2.1 MacroGenics, Inc. Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 MacroGenics, Inc. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 MacroGenics, Inc. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Products Offered
      • 11.2.5 MacroGenics, Inc. Recent Development
    • 11.3 Shire Plc
      • 11.3.1 Shire Plc Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Shire Plc Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Shire Plc Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Products Offered
      • 11.3.5 Shire Plc Recent Development
    • 11.4 Xencor, Inc.
      • 11.4.1 Xencor, Inc. Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Xencor, Inc. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Xencor, Inc. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Products Offered
      • 11.4.5 Xencor, Inc. Recent Development

    12 Future Forecast

    • 12.1 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Forecast by Regions
      • 12.1.1 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Forecast by Regions 2019-2025
    • 12.2 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Forecast by Product
      • 12.2.1 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Forecast by Product 2019-2025
      • 12.2.2 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Forecast by Product 2019-2025
    • 12.3 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Forecast by End User
    • 12.4 North America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Forecast
    • 12.5 Europe Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Forecast
    • 12.6 Asia Pacific Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Forecast
    • 12.7 Central & South America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Forecast
    • 12.8 Middle East and Africa Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b . Industry analysis & Market Report on Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b is a syndicated market report, published as Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,010.80
      4,516.20
      6,021.60
      3,584.10
      5,376.15
      7,168.20
      593,073.00
      889,609.50
      1,186,146.00
      328,224.00
      492,336.00
      656,448.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report